Abstract:Objective: To investigate the changes and clinical significance of serum C-reactive protein (CRP), amylase (AMY), and mean platelet volume (MPV) in patients with biliary pancreatitis. Methods: Ninety eight patients with acute biliary pancreatitis (biliary source group) and 100 patients with acute non biliary pancreatitis (control group) diagnosed at the same time in Huangshan People's Hospital from June 2019 to June 2022 were selected. The levels of CRP, AMY, MPV, liver function indicators, blood routine biochemical indicators, acute physiological function and chronic health (APACHE II) scores, and CT severity index scores (CTSI) of the two groups were compared. Simple linear correlation was used to analyze the correlation between CRP, AMY, MPV levels, APACHE Ⅱ score and CTSI. Results: There was no statistically significant difference between the two groups in serum CRP and AMY measured values (P>0.05); the measured value of MPV in peripheral blood of the biliary group was higher than that of the control group, and the difference between the above indexes was statistically significant (P<0.05); the serum ALT, AST, TBIL and DBIL of patients in the biliary group were higher than those in the control group, and the difference between the above indexes was statistically significant (P<0.05); there was no statistically significant difference in urea nitrogen, WBC, blood sugar, blood calcium, lactate dehydrogenase, hemoglobin, hematocrit, platelet count, APACHE Ⅱ score and CTSI score between the biliary group and the control group (P>0.05); the correlation analysis of CRP, AMY, MPV, APACHE Ⅱ score and CTSI score of patients in biliary group showed that there was significant positive correlation (P<0.05); the level of MPV in peripheral blood has high value in differential diagnosis of patients with acute biliary pancreatitis or acute non biliary pancreatitis, with sensitivity of 70.63%, specificity of 64.75%, AUC value of 0.746 (95% CI: 0.679-0.813), and cutoff value of ≥ 9.20 fL. Conclusion: The levels of CRP and AMY in patients with acute biliary pancreatitis or acute non-biliary pancreatitis are not significantly different, MPV is higher than that in patients with acute non-biliary pancreatitis, CRP, AMY, MPV and acute biliary pancreatitis patients Depending on the severity, MPV has a certain value in the differential diagnosis of acute biliary pancreatitis or acute non-biliary pancreatitis.
花雷, 魏伟, 杜勇, 王煜. 胆源性胰腺炎患者血清CRP AMY MPV的变化在诊断及病情评估中的价值[J]. 河北医学, 2023, 29(6): 972-976.
HUA Lei, WEI Wei, DU Yong, et al. The Value of Changes in Serum CRP, AMY and MPV in Diagnosis and Disease Assessment of Patients with Biliary Pancreatitis. HeBei Med, 2023, 29(6): 972-976.
[1] Kaur G,Padiya R,Adela R,et al.Garlic and resveratrol attenuate diabetic complications,loss of β-cells,pancreatic and hepatic oxidative stress in streptozotocin-induced diabetic rats[J].Front Pharmacol,2016,13(7):360. [2] PieirolV,Rauep,Delgadopa,et al.Predictors of persistent common bile duct stones in mild acute biliary pancreatitis;the role of liver enzyme and dilated CBD on ultrasound[J].HPB,2019,21(8):730-732. [3] 中华医学会消化病学分会胰腺疾病学组,中华胰腺病杂志编辑委员会,中华消化杂志编辑委员会.中国急性胰腺炎诊治指南(2019年,沈阳)[J].中华消化杂志,2019,39(11):721-730. [4] Para O,Caruso L,Savo MT,et al.The challenge of prognostic markers in acute pancreatitis:internist's point of view[J].Genet Eng Biotechnol,2021,19(1):77. [5] Liu N,He J,Hu X,et al.Acute necrotising pancreatitis:measurements of necrosis volume and mean CT attenuation help early prediction of organ failure and need for intervention[J].Eur Radiol,2021,31(10):7705-7714. [6] 黄景玉,刘红书.多层螺旋CT检查联合生化指标检测在急性胰腺炎诊断中的应用价值[J].影像科学与光化学,2020,38(4):637-641. [7] Esmer D,Rivera-Villalobos O,Hernandez-Sierra JF,et al.Immediate feeding tolerance in patients with mild acute biliary pancreatitis[J].Cir Cir,2021,89(2):243-247. [8] 梁育岑,梁育霞,王洪涛,等.胆源性胰腺炎患者血清CRP、ET-1、AMY、ALT、AST等水平及临床意义[J].检验医学与临床,2021,18(16):2427-2430. [9] 王煜晔,高飞,高峰,等.内镜下逆行胰胆管造影术治疗急性胆源性胰腺炎的疗效分析[J].中华胰腺病杂志,2019,19(3):177-180. [10] 邓中波,叶淳娟,徐玉龙.血清血小板平均体积CRP纤维蛋白原与急性胰腺炎患者病情程度和预后转归的关系分析[J].河北医学,2022,28(4):670-675.